Spirent Notice of 2024 Half Year Results
SPIRENT COMMUNICATIONS PLC
Notice of 2024 Half Year Results
London, UK - 2 July 2024: Spirent Communications plc ("Spirent" or the "Company") (LSE: SPT), the leading provider of automated test and assurance solutions for next-generation devices and networks will announce its half year results for the six months ended 30 June 2024 on Tuesday, 6 August 2024, before the opening of the UK market.
- ends -
Enquiries
|
Eric Updyke, Chief Executive Officer |
|
Spirent Communications plc |
|
+44 (0)1293 767676 |
|
Paula Bell, Chief Financial & Operations Officer |
|
|
|
|
|
|
|
|
|
|
|
James Melville-Ross/ |
|
DGA Group |
|
+44 (0)20 7664 5095
|
About Spirent Communications plc
Spirent Communications plc (LSE: SPT) is the leading global provider of automated test and assurance solutions for networks, cybersecurity and positioning. The Company provides innovative products, services and managed solutions that address the test, assurance and automation challenges of a new generation of technologies, including 5G, SD-WAN, Cloud, autonomous vehicles and beyond. From the lab to the real world, Spirent helps companies deliver on their promise to their customers of a new generation of connected devices and technologies. Further information about Spirent Communications plc can be found at https://corporate.spirent.com/.
Spirent Communications plc Ordinary Shares are traded on the London Stock Exchange (ticker: SPT; LEI: 213800HKCUNWP1916L38). The Company operates a Level 1 American Depositary Receipt (ADR) programme with each ADR representing four Spirent Communications plc Ordinary Shares. The ADRs trade in the US over-the-counter (OTC) market under the symbol SPMYY and the CUSIP number is 84856M209. Spirent ADRs are quoted on the Pink OTC Markets electronic quotation service which can be found at https://www.otcmarkets.com/marketplaces/otc-pink.
Spirent and the Spirent logo are trademarks or registered trademarks of Spirent Communications plc. All other trademarks or registered trademarks mentioned herein are held by their respective companies. All rights reserved.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 6 hours ago Cambridge Cognition Holdings
- 7 hours ago Shell
- 7 hours ago Centrica
- 8 hours ago Optima Health
- 8 hours ago Centrica